Bitcoin Cash faces critical technical juncture at $464 with neutral momentum. BCH price prediction suggests $550-$670 targets within 30 days if key resistance breaksBitcoin Cash faces critical technical juncture at $464 with neutral momentum. BCH price prediction suggests $550-$670 targets within 30 days if key resistance breaks

BCH Price Prediction: Targets $550-$670 by April 2026

2026/03/23 15:11
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

BCH Price Prediction: Targets $550-$670 by April 2026

Luisa Crawford Mar 23, 2026 07:11

Bitcoin Cash faces critical technical juncture at $464 with neutral momentum. BCH price prediction suggests $550-$670 targets within 30 days if key resistance breaks.

BCH Price Prediction: Targets $550-$670 by April 2026

BCH Price Prediction Summary

Short-term target (1 week): $478-$485 • Medium-term forecast (1 month): $550-$670 range
Bullish breakout level: $478.50 • Critical support: $454.10

What Crypto Analysts Are Saying About Bitcoin Cash

Recent analyst predictions from early 2026 painted an optimistic picture for Bitcoin Cash. Tony Kim projected BCH could reach the "$670-$720 range within 30 days" citing "MACD bullish momentum and strong support at $580." Similarly, Felix Pinkston suggested "a potential 16.6% rally to $750 within 30 days," while James Ding highlighted analyst projections for "$720-750 targets within 30 days."

However, current market conditions show Bitcoin Cash trading well below these earlier optimistic forecasts. The consensus targets of $720-$750 from January analysts now appear overly ambitious given BCH's current position at $464.70.

According to on-chain data from major platforms, Bitcoin Cash faces technical headwinds that weren't fully anticipated in earlier predictions.

BCH Technical Analysis Breakdown

Bitcoin Cash currently trades at $464.70, showing bearish divergence from longer-term moving averages. The cryptocurrency sits below both its 50-day SMA at $494.77 and 200-day SMA at $545.51, indicating medium to long-term bearish sentiment.

RSI Analysis: At 46.28, BCH's RSI remains in neutral territory, suggesting neither oversold nor overbought conditions. This provides room for movement in either direction without immediate technical constraints.

MACD Signals: The MACD histogram at 0.0000 with a reading of -7.6059 indicates bearish momentum has stalled but hasn't reversed. This neutral-to-bearish setup suggests caution for bullish positions.

Bollinger Bands Position: BCH trades at 0.62 relative to its Bollinger Bands, positioned above the middle band ($460.16) but well below the upper band at $479.83. This suggests moderate bullish positioning within the recent range.

Key Levels: Immediate resistance sits at $471.60, with stronger resistance at $478.50. Support levels are established at $459.40 (immediate) and $454.10 (strong support).

Bitcoin Cash Price Targets: Bull vs Bear Case

Bullish Scenario

A Bitcoin Cash forecast under bullish conditions targets the $550-$670 range within 30 days. This scenario requires BCH to break above the critical $478.50 resistance level, which would trigger:

  • Initial target: $485-$495 (approaching the 50-day SMA)
  • Secondary target: $520-$530 (halfway to 200-day SMA)
  • Extended target: $550-$670 (matching revised analyst expectations)

Technical confirmation would come from RSI breaking above 50, MACD turning positive, and sustained trading above the upper Bollinger Band at $479.83.

Bearish Scenario

The bearish Bitcoin Cash forecast sees potential downside to $420-$440 if current support fails. Key risk factors include:

  • Break below $454.10 strong support
  • Failure to reclaim the 20-day SMA at $460.16
  • MACD remaining in negative territory
  • Bitcoin weakness dragging altcoins lower

A bearish break would target the $440-$450 range initially, with extended downside to $420 if selling pressure intensifies.

Should You Buy BCH? Entry Strategy

Current BCH price prediction suggests a cautious approach given mixed technical signals. Potential entry strategies include:

Conservative Entry: Wait for a clear break above $478.50 resistance with volume confirmation before entering long positions.

Aggressive Entry: Accumulate near current levels ($464-$466) with tight stops below $454.10.

Dollar-Cost Averaging: Gradual accumulation between $450-$470 for medium-term positions targeting $550-$670.

  • Conservative: $449 (below strong support)
  • Aggressive: $459 (below immediate support)

Risk management remains crucial given BCH's daily ATR of $15.16, indicating significant intraday volatility.

Conclusion

This BCH price prediction reflects a cautiously optimistic outlook with targets of $550-$670 over the next 30 days, representing potential gains of 18-44% from current levels. However, Bitcoin Cash must first overcome immediate resistance at $478.50 to validate this Bitcoin Cash forecast.

The neutral RSI and stalled MACD suggest BCH is at a technical inflection point. A break above key resistance could trigger the bullish scenario, while failure to hold support near $454 could extend the current consolidation lower.

Confidence Level: Medium (60%) - Technical setup shows mixed signals requiring confirmation

Disclaimer: Cryptocurrency price predictions are speculative and subject to high volatility. This analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research and consider your risk tolerance before investing.

Image source: Shutterstock
  • bch price analysis
  • bch price prediction
Market Opportunity
Bitcoin Cash Node Logo
Bitcoin Cash Node Price(BCH)
$467,1
$467,1$467,1
-0,34%
USD
Bitcoin Cash Node (BCH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Supported by hike speculation and PMIs – Danske Bank

Supported by hike speculation and PMIs – Danske Bank

The post Supported by hike speculation and PMIs – Danske Bank appeared on BitcoinEthereumNews.com. Danske Research Team points out that the Euro was the second-
Share
BitcoinEthereumNews2026/03/23 15:59
The geopolitics of anti-corruption as global advisory firms face debarment in the Horn of Africa

The geopolitics of anti-corruption as global advisory firms face debarment in the Horn of Africa

The World Bank’s debarment of PwC and EY for fraud in Ethiopia and Somalia has lifted the veil on the fragility of the Western development model, creating a strategic
Share
Theexchange2026/03/23 16:33
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11